Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Company reported the results of its 2026 annual shareholder meeting. Of 114,349,911 common shares outstanding, 100,631,008 were represented by proxy or virtually, so business could proceed. Shareholders elected eleven directors to one-year terms and ratified PricewaterhouseCoopers LLP as independent auditor for 2026.
Investors cast an advisory "say-on-pay" vote approving the company’s executive compensation, and also approved the 2026 Omnibus Stock Compensation Plan. A shareholder proposal to lower the ownership threshold for calling special shareholder meetings to 10% did not receive majority support and was not adopted.
Alfonso Humberto P reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Humberto P. Alfonso received a grant of 1,628 Phantom Stock Units on May 7, 2026. These units are part of the Directors' Deferred Compensation Plan and each unit’s value equals one share of Eastman common stock.
The award represents the deferral, at the director’s election, of the value of his annual non-employee director restricted stock award that would otherwise have been paid in common stock. The Phantom Stock Units vest on May 7, 2027 and are payable only in cash. Following this grant, the director holds 57,588 Phantom Stock Units in total.
BEGEMANN BRETT D reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Brett D. Begemann reported a routine compensation transaction involving phantom stock units tied to Eastman Chemical common stock. He received an award of 1,628 Phantom Stock Units, each valued at $73.69, credited under the company’s Directors' Deferred Compensation Plan.
These units are unvested, will vest on May 7, 2027, and are payable only in cash, meaning they do not represent actual shares or voting rights. Following this award, Begemann now holds 60,034 Phantom Stock Units in total, reflecting deferred, cash-settled director compensation rather than an open-market stock purchase.
Mink Kim Ann reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Kim Ann Mink reported receiving a grant of 1,628 Phantom Stock Units tied to the company’s common stock value at $73.69 per unit. This compensation-related award increases her Phantom Stock Unit balance to 17,280 units. The units are unvested, will vest on May 7, 2026, and are payable only in cash under the Directors' Deferred Compensation Plan. The grant reflects her election to defer the value of an annual non-employee director restricted stock award that otherwise would have been paid in common stock.
SLAGER DONALD W reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Donald W. Slager received an equity grant of 1,628 shares of common stock. This was a grant or award, not an open-market purchase or sale, and carried a price of $0.00 per share as compensation rather than a cash transaction.
The shares are restricted, with restrictions scheduled to lapse on May 7, 2027, subject to conditions tied to his continued service as a director. Following this grant, Slager directly holds a total of 3,303 shares of Eastman Chemical common stock.
Holder Julie Fasone reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Julie Fasone Holder received a grant of 1,628 shares of common stock as a restricted stock award. The shares were granted at no cash cost and will remain restricted until May 7, 2027, contingent on her continued service as a director. Following this award, she directly holds 19,174 shares of Eastman Chemical common stock.
Eastman Chemical Company director Renee J. Hornbaker received a grant of 1,628 shares of common stock as a restricted stock award. The restrictions are scheduled to lapse on May 7, 2027, subject to her continued service as a director. Following this award, she directly holds 25,565 shares, which include 154 shares acquired through automatic dividend reinvestment since May 1, 2025.
OBRIEN JAMES J /KY reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director James J. O'Brien received a grant of 1,628 shares of common stock as a restricted stock award. The award was granted at no cash cost and represents his annual Restricted Stock Award. After this grant, he holds 8,456 shares directly.
The restricted shares are scheduled to lapse on May 7, 2027, subject to conditions tied to his continued service as a director. In addition to his direct holdings, he also indirectly owns 1,022 shares through a revocable trust.
BUTLER ERIC L reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Eric L. Butler received a grant of 1,628 shares of common stock as a restricted stock award. The shares were awarded at no cash cost per share and represent his annual Restricted Stock Award as a director. Following this grant, Butler directly holds 10,958 shares of Eastman Chemical common stock. The restrictions on these shares will lapse on May 7, 2027, subject to conditions tied to his continued service as a director.
Eastman Chemical Company director Linnie M. Haynesworth received an annual equity grant in the form of restricted common shares. On May 7, 2026, she acquired 1,628 shares at no cash price as a grant or award, increasing her direct holdings to 3,135 shares. These are restricted shares, with restrictions scheduled to lapse on May 7, 2027, subject to conditions related to her continued service as a director. The share amount represents her annual Restricted Stock Award, reflecting routine director compensation rather than an open-market purchase or sale.